News & Events

Latest Blog Posts & Events

Study Finds Prenatal Test Results Can Reveal Cancer in Mothers
In some cases where the fetus was developing normally, abnormal NIPT results were found to be caused by the mother’s undiagnosed cancer.
FDA Approves Nivolumab Injections
The new formulation of this commonly used immunotherapy drug cuts treatment time from 30 minutes to 5 minutes.
Treatment Guidelines for Metastatic Prostate Cancer Aren't Always Trickling Down into Practice
In a survey, many U.S. doctors reported not using the recommended treatments for patients with hormone-sensitive disease.

Latest Press Releases

Gene therapy shows clinical benefit in patients with a debilitating disorder caused by HPV
- February 13, 2025
An NCI clinical trial showed that an experimental gene therapy called PRGN-2012 may be an effective treatment for recurrent respiratory papillomatosis, which is caused by HPV 6 and HPV 11.
In five cancer types, prevention and screening have been major contributors to saving lives
- December 5, 2024
Over the past 45 years, the majority of deaths averted from breast, cervical, colorectal, lung, and prostate cancer were due to prevention and screening, rather than treatment advances, NCI researchers have found.
Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers
- November 11, 2024
A new study led by NCI researchers shows that mutant RAS proteins help release a nuclear protein from a complex transported from the nucleus to the cytoplasm, kicking off a series of events that lead to the breakdown of a tumor suppressor protein.
NIH-funded scientists uncover clues to precancer and tumor biology
- October 30, 2024
New studies released by NCI’s Human Tumor Atlas Network explore the role of the tumor microenvironment and the immune system in promoting the spread of cancer and its resistance to treatment. The studies appear across several Nature journals.
NIH clinical trial will test precision medicine treatments for myeloid cancers
- October 23, 2024
NCI has launched myeloMATCH, a precision medicine treatment trial that will test treatment combinations targeting specific genetic changes in people with acute myeloid leukemia and myelodysplastic syndromes.